174 related articles for article (PubMed ID: 7052342)
21. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells.
Bartrup JT; Newberry NR
J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467
[TBL] [Abstract][Full Text] [Related]
22. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
Friedman RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
[TBL] [Abstract][Full Text] [Related]
23. Generation of an unusual depolarizing response in rabbit primary afferent neurones in the absence of divalent cations.
Stansfeld CE; Wallis DI
J Physiol; 1984 Jul; 352():49-72. PubMed ID: 6086912
[TBL] [Abstract][Full Text] [Related]
24. Effects of DU 24565 (6-nitroquipazine) on serotoninergic and noradrenergic neurones of the rat brain and comparison with the effects of quipazine.
Classen K; Göthert M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(3):198-202. PubMed ID: 6206407
[TBL] [Abstract][Full Text] [Related]
25. Modulation of afferent-evoked neurotransmission by 5-HT3 receptors in young rat dorsal horn neurones in vitro: a putative mechanism of 5-HT3 induced anti-nociception.
Khasabov SG; Lopez-Garcia JA; Asghar AU; King AE
Br J Pharmacol; 1999 Jun; 127(4):843-52. PubMed ID: 10433490
[TBL] [Abstract][Full Text] [Related]
26. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion.
Ireland SJ; Jordan CC
Br J Pharmacol; 1987 Oct; 92(2):417-27. PubMed ID: 3676602
[TBL] [Abstract][Full Text] [Related]
28. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
29. Effects of quipazine on pre- and postsynaptic serotonin receptors: single cell studies in the rat CNS.
Blier P; de Montigny C
Neuropharmacology; 1983 Apr; 22(4):495-9. PubMed ID: 6856049
[TBL] [Abstract][Full Text] [Related]
30. Characterization of 5-hydroxytryptamine receptors in rabbit isolated iliac artery.
Yildiz O; Tuncer M
Arch Int Pharmacodyn Ther; 1993; 326():72-83. PubMed ID: 8185415
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of reflex responses of neonate rat lumbar spinal cord by 5-hydroxytryptamine.
Crick H; Wallis DI
Br J Pharmacol; 1991 Jul; 103(3):1769-75. PubMed ID: 1933139
[TBL] [Abstract][Full Text] [Related]
32. Blockade of 5-hydroxytryptamine (5-HT) receptors by quipazine [proceedings].
Lansdown MR; Nash HL; Preston PR; Wallis DI
Br J Pharmacol; 1979 May; 66(1):80P-81P. PubMed ID: 454965
[No Abstract] [Full Text] [Related]
33. Excitatory and inhibitory effects of serotonin on spinal axons.
Saruhashi Y; Young W; Hassan AZ; Park R
Neuroscience; 1994 Aug; 61(3):645-53. PubMed ID: 7969935
[TBL] [Abstract][Full Text] [Related]
34. Effects of quipazine on blood pressure in pithed rats.
Shin YK; Svinareff P; Schmitt-Jubeau H; Schmitt H
Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
Prins NH; Briejer MR; Schuurkes JA
Br J Pharmacol; 1997 Feb; 120(4):714-20. PubMed ID: 9051313
[TBL] [Abstract][Full Text] [Related]
36. Relative activities of substances related to 5-hydroxytryptamine as depolarizing agents of superior cervical ganglion cells.
Wallis D; Nash H
Eur J Pharmacol; 1981 Mar; 70(3):381-92. PubMed ID: 7227456
[TBL] [Abstract][Full Text] [Related]
37. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
[TBL] [Abstract][Full Text] [Related]
38. 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies.
Piñeyro G; de Montigny C; Blier P
Neuropsychopharmacology; 1995 Nov; 13(3):249-60. PubMed ID: 8602897
[TBL] [Abstract][Full Text] [Related]
39. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiological studies on the interaction of 5-hydroxytryptamine with sympathetic transmission in the guinea pig inferior mesenteric artery and ganglion.
Meehan AG; Kreulen DL
J Pharmacol Exp Ther; 1991 Jan; 256(1):82-7. PubMed ID: 1846426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
